Immunohistochemical Study of p53 Gene Expression in Astrocytic Neoplasms.
- Author:
Kum WHANG
1
;
Yong Pyo HAN
;
Mi Yon CHO
;
Sun Hee JUNG
;
Hun Ju KIM
Author Information
1. Department of Neurosurgery, Wonju College of Medicine, Yonsei University, Wonju, Korea.
- Publication Type:Original Article
- Keywords:
Astrocytic neoplasm;
Immunohistochemical staining;
P53 gene expression;
Histopathologic grade
- MeSH:
Animals;
Astrocytoma;
Classification;
Genes, p53*;
Glioblastoma;
Mice;
Survival Rate
- From:Journal of Korean Neurosurgical Society
1995;24(3):231-238
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nineteen astrocytic neoplasms, such as 9 cases of glioblastoma multiforme, 6 cases of anaplastic astrocytoma and 4 cases of low grade astrocytoma, were analysed in view of the relationship between histopathologic grade, nuclear pleomorphism, grade of mutant p53 gene expression and mean survival time after operation. The histopathologic classification by Ringertz and immunohistochemical stain for mutant p53 gene with the DO-7 anti-p53 oncoprotein mouse monoclonal antibody were applied, and the results obtained were as follows; 1) Among 19 cases, 18 cases were located in the supratentorium, where 13 cases(42%) were located in the left and 17 cases(55%) in the right. 2) The p53 gene expression was detected in 12(63.2%) of the cases, as revealed by positive nuclear staining. All cases of glioblastoma multiforme showed p53 gene expression, compared with two(33.3%) cases of anaplastic astrocytoma and one(25%) case of low grade astrocytoma. The frequency and degree of histopathologic grade(p=0.03). 3) The mean survival time after operation was 29.49+/-4.08 months in cases with p53-negative tumors and 12.93+/-3.14 months in cases with p53-positive tumors(p<0.05). 4) Both histopathological classification and p53 gene expression showed a significant influence on servival(p=0.02 and p=0.03, respectively). 5) The relative risk for survival time was the highest in p53 gene expression. In conclusion, p53 gene expression appears to be one of the recommendable prognosticators among astrocytic neoplasms.
